Although it is well known that phosphodiesterase V inhibitors, used to treat patients with ED, can improve the endothelial dysfunction in organic vascular forms, few studies have explored the duration of their effect on the endothelium after discontinuation. Therefore, the purpose of this study was to evaluate the serum concentrations of apoptotic endothelial microparticles (EMPa), selected as a marker of endothelial damage, in patients with arterial ED at baseline, during tadalafil administration and 3 and 6 months after its discontinuation. In all, 50 patients with arterial ED were evaluated at baseline and 1 week after administration of tadalafil 5 mg once daily for 90 days. Clinical (International Index of Erectile Function-5 score), instrumental (dynamic penile echo color Doppler) and flow-cytometric (serum EMPa concentrations) analyses were performed before (T0) and 1 week (T1), 3 months (T2) and 6 months (T3) after tadalafil discontinuation. The events CD45 neg /CD144 pos /annexinV pos were defined as EMPa. At T0, patients with arterial ED had serum EMPa concentration significantly higher than 20 healthy men (controls). At T1, patients with arterial ED showed a serum EMPa concentration significantly lower than T0. The significant difference was maintained, though reduced, at T2 and completely lost at T3. In conclusion, the administration of tadalafil decreased serum EMPa concentration in patients with arterial ED. This positive effect on the endothelial dysfunction disappeared 6 months after tadalafil discontinuation.
Introduction
Patients with arterial ED have a variable degree of endothelial dysfunction, especially when ED is associated with cardiovascular risk factors. 1 Therefore, the endothelial diagnosis is considered very important for a better classification of these patients. Nowadays, the evaluation of endothelial dysfunction in patients with ED is carried out by different complementary methods involving hemodynamic tests (flow-mediated dilation, peripheral arterial tonometry and penile nitric oxide release test), serum parameters (C-reactive protein, endothelin-1, vascular cell adhesion molecule-1 and asymetric dimethylarginine) and cellular markers (endothelial progenitor cells). 2 Recently, the role of the endothelial microparticles (EMP) as markers of endothelial apoptosis has been proposed. EMP arise from the endothelial lining of blood vessels and by general consensus are small (p1.5 mm). In particular, the externalization of phosphatidylserine (PS) is a key molecular event that indicates the initial loss of the membrane integrity. 3 EMPs not only constitute an emerging marker of endothelial dysfunction, but are also considered to have a major biological role in inflammation, vascular injury, angiogenesis and thrombosis. Although the mechanisms leading to their in vivo formation remain obscure, the release of EMP from in vitro cultured cells can be induced by a number of cytokines and apoptotic stimuli. Recent studies indicate that EMPs are able to decrease nitric-oxide-dependent vasodilation, increase arterial stiffness, promote inflammation and initiate thrombosis at their PS-rich membrane, which highly co-expresses tissue factor.
EMPs are known to be elevated in acute coronary syndromes, in severe hypertension with end organ damage and in thrombotic thrombocytopenic purpura, all conditions associated with endothelial injury and pro-thrombotic state. The release of EMPs has also been associated with endothelial dysfunction of patients with multiple sclerosis and lupus anti-coagulant. More recent studies have focused on the role of low shear stress leading to endothelial cell apoptosis and subsequent EMP release in end-stage renal disease. Improved knowledge of EMP composition, their biological effects and the mechanisms leading to their clearance will probably open new therapeutic approaches in the treatment of atherothrombosis. 4 Apoptosis of intima and media tunics artery is a traumatic event and therefore helps to promote the development of atherosclerosis and the capacity of the arterial wall to oppose apoptosis, and self-repairing is emerging as a possible key element in the prevention of atherosclerotic disorders. 5 Esposito et al. 6 reported that patients with diabetes mellitus have higher concentrations of EMP31 pos (apoptotic marker), while diabetic and non-diabetic patients with ED have higher concentrations of EMP62 pos (markers of activation), compared with subjects without ED or diabetes mellitus. The EMP62 pos /EMP31 pos ratio, an index of endothelial activation, was lower in patients with ED and diabetes mellitus. No studies have so far examined the expression of these elements in patients with vascular ED at baseline and/or after treatment with PDE5i. Other methods to evaluate endothelial dysfunction have suggested an improvement of endothelial apoptosis in men with ED after treatment with tadalafil or other PDE5i. 7, 8 Recently, a study evaluated the duration of response after tadalafil (once daily) discontinuation in patients with ED. This retrospective analysis examined durability, defined as sustainability of erectogenic benefits following treatment cessation, in 160 patients who had participated in a 12-week double-bind trial followed by a 1-year open-label extension of tadalafil 5 mg once daily. The extension was followed by a 4-week treatment-free follow-up period. The primary measures for this analysis were changes in ED severity category as captured by the International Index of Erectile Function-5 (IIEF-5) score. The results showed that at the end of the 1-year open-label treatment period, a majority (86.1% out of 136) of subjects had either improved by at least one ED severity category (for example, severe-moderate) or maintained normal erectile function compared with baseline. Following the 4-week treatment-free period, 63 out of the 136 patients (46.3%) had a continued improvement of at least one ED severity category or maintained scores in the normal category compared with baseline. Subjects who showed a sustained benefit of treatment were considered to have a 'durable response'. In all, 73 subjects (53.7%) did not have a durable response following treatment cessation. 9 This study provides interesting information, although limited to the clinical response alone.
Therefore, on the basis of these premises, the aim of this study was to evaluate the serum concentration of EMP with PS externalization (EMPa), selected as a marker of endothelial apoptosis, by flow cytometry, in patients with arterial ED and without other systemic arterial involvement, at baseline (T0) and 1 week (T1), 3 months (T2) and 6 months (T3) after tadalafil (5 mg once daily for 90 days) discontinuation. At these time points, IIEF-5 score and dynamic penile echo color Doppler were also performed.
Materials and methods
A total of 50 consecutive patients with ED of arterial origin were enrolled in this study. All patients showed the following characteristics: IIEF-5 o21, The following exclusion criteria were applied: smokers (45 cigarettes per day), hypogonadism, carotid and/or femoral atherosclerosis and chronic ischemic heart disease. Patients with ED were evaluated at baseline (T0), during tadalafil administration (5 mg daily for 90 days) (T1) and 3 (T2) and 6 (T3) months after tadalafil discontinuation. The evaluation consisted of IIEF-5 administration, ultrasound evaluation, dynamic penile echo color Doppler and also carotid artery plus lower limbs echo color Doppler; finally, they underwent to blood sampling for flowcytometric of EMPa performed at each of these time points. In all, 20 healthy men were selected to evaluate the serum EMPa concentration in normal healthy men. All patients signed an informed consent. The study was approved by the Institutional Review Board. Endothelium-derived microparticles with PS externalization (EMPa) Blood was drawn into citrate vacutainers in the morning after an overnight fast. The blood was lysed with specific solutions (VersaLyse, Milan, Italy) and then centrifuged with short spin at high speed.
Flow cytometric analysis
Endothelial apoptosis after tadalafil discontinuation S La Vignera et al Samples were processed within 2 h after being obtained. They were centrifuged for 10 min at 160 Â g to prepare platelet-rich plasma, then centrifuged for 10 min at 1000 Â g to prepare platelet-poor plasma. EMPs were measured by flow cytometry. In brief, 50 ml of platelet-poor plasma was incubated (20 min) with the following panel of monoclonal antibodies: CD45 (10 ml), CD144 (20 ml) and annexin V (1 ml), respectively, marked with ECD, PE and FITC, for 20 min at room temperature. The samples were then washed with phosphate-buffered saline and read at the flow cytometer. The events CD45 neg /CD144 pos /annexin V pos were defined as EMPa. The analysis was considered informative when at least 100 events with these characteristics passed through the windows of assessment. Control isotope IgG1 and IgG2a antibodies were performed. EMPa were calculated as percentage of the CD45 neg fraction of circulating white blood cells.
Statistical analysis
Results are shown as mean ± s.e.m. throughout the study. EMPa data were log-transformed before being analyzed. Statistical analysis was conducted by oneway analysis of variance followed by the Duncan multiple-range test or paired or unpaired Student's t-test, as appropriate. Correlation analysis was carried out by Pearson test. Statistical analysis was conducted using SPSS 9.0 for Windows (SPSS Inc., Chicago, IL, USA). A P value lower than 0.05 was accepted as statistically significant.
Results

At baseline (T0)
The 50 patients enrolled in this study had a mean age of 56±2 years (range: 50-59 years) and an average IIEF-5 score of 6.5 ± 1.0 (range 4-12). Controls had a mean age of 58 ± 4 years (range: 51-62 years) and an average IIEF-5 score of 23.0±1.0 (range 21-25). No statistically significant difference was observed for age, body mass index and main metabolic parameters between patients with ED and controls ( Table 1) .
ED patients had significantly lower PSV, whereas acceleration time and intima-media thickness were significantly higher compared with controls (Po0.05) ( Table 2) . PSV correlated significantly with the IIEF-5 score (r ¼ 0.76, Po0.001), whereas the acceleration time (r ¼ À0.77, Po0.001) and intima-media thickness (r ¼ À0.76, Po0.001) showed a highly significant negative correlation with the IIEF-5 score.
At baseline, patients with arterial ED had a concentration of circulating EMPa significantly higher (12.2 ± 2.2%) than controls (1.8 ± 0.4%) (Po0.05) ( Table 2) .
One week after tadalafil discontinuation (T1) ED patients showed a mean values of IIEF-5 score significantly higher (16.0±1.0 (range 4-22)), compared with baseline. In addition, they showed significantly higher values of PSV (37.5 ± 2.0 cm s À1 ), whereas the acceleration time (106.3±10.5 mms) was significantly lower (Po0.05), compared with baseline. The serum concentration of circulating EMPa was significantly lower (7.2 ± 1.1%) compared with baseline (Po0.05) ( Table 3) . (Table 3) . ), whereas the acceleration time (110.3±8.5 mms) was significantly lower (Po0.05) compared with the baseline. The IIEF-5 score and the others dynamic penile echo color Doppler parameters investigated did not differ from those at T2. The serum concentration of EMPa was significantly higher than T2 (Po0.05) and similar to T0 (Table 3) .
Six months after tadalafil discontinuation (T3)
ED
Discussion
The present study evaluated a group of patients with arterial ED, without other apparent systemic arterial involvement, who showed a significant increase of endothelial apoptosis, as assessed by flow cytometric detection of EMPa. The results also showed that the daily administration of tadalafil reduces endothelial apoptosis, but its potential curative role lasts less than 6 months after treatment discontinuation.
The EMPa immunophenotype evaluated in this study included CD144 and PS antigens. CD144 is a single-chain, trans-membrane protein whose aminoacid sequence indicates its homology with cadherins and, because of this, it has also been named vascular-endothelial cadherin or cadherin 5. Cadherins have been called into role in the endothelial intercellular contacts, together with integrins and some immunoglobulin family members, where they promote the hemophilic and calcium-dependent intercellular recognition. Structurally, cadherins are single-chain, transmembrane glycoproteins located in specialized structures called adherent junctions. CD144 is specifically expressed in the endothelial cells where it organizes adherent junctions. These junctions control permeability and migration and they are partially responsible to inhibit growth by contact. [13] [14] [15] The externalization of PS indicates the loss of the integrity of the membrane that in the vascular disease, is the final expression of endothelial injury or trauma. 3, 4, 16 Apoptosis, a programmed cell death, has an important role in the initiation and progression of a number of cardiovascular disease, such as heart failure, myocardial infarction and atherosclerosis. One of the most prominent characteristics of apoptosis is the externalization of PS, a plasma cell membrane phospholipid, which in healthy cells only is present on the inner leaflet of the plasma cell membrane. Annexin V, a 35-kD plasma protein, has strong affinity for PS in the nano-molar range. Through the coupling of annexin V to contrast agents, visualization of apoptotic cell death in vivo in animal models and in patients has become feasible. These imaging studies have provided novel insight into the extent and kinetics of apoptosis in cardiovascular disease. Furthermore, annexin V imaging has proven to be a suitable imaging biomarker for the evaluation of cell-death-modifying compounds and plaque-stabilizing strategies. Recent insight in PS biology has shown that PS externalization not only occurs in apoptosis, but is also observed in activated macrophages and stressed cells. 17 Other studies using different in vitro methodologies, investigated the effects of tadalafil and of other PDE5i administration on endothelial apoptosis. Lysiak et al. 8 showed that treatment with tadalafil prevents apoptosis as well as the specific mechanisms involved, resulting in a decreased number of apoptotic cells and increased phosphorylation of the two survival-associated kinases Akt and extracellular signal-regulated kinase 1/2. Endothelial apoptosis after tadalafil discontinuation S La Vignera et al Park et al. 7 examined whether chronic treatment with a PDE5i could suppress corporal apoptosis via potentiation of Akt signaling in diabetic ED. In this study, chronic treatment with PDE5i activated Akt signaling, which suppressed pro-apoptotic stimuli and maintained erectile function in rat model of diabetic ED. PDE5i treatment also significantly inhibited the activities of cavernousal caspase 3 and caspase 9, the main effectors of apoptosis.
The durability of the effect of continuous treatment with tadalafil (5 mg once daily) is commonly assessed by evaluating its efficacy and tolerability. In a recent long-term, open-label, once-daily dosing study, tadalafil was well tolerated and effective, making it a viable alternative to the current ondemand dosing of tadalafil for men with ED. In this study, safety measures included adverse events, electrocardiograms and clinical laboratory measures. Efficacy measures included the IIEF-5, intercourse satisfaction and overall satisfaction domain scores and the global assessment questions (GAQ1: improved erections; GAQ2: improved ability to engage in sexual activity). Overall investigated two schemes of tadalafil treatment in improving endothelium-dependent vasodilatation of cavernous arteries in men with ED, and whether this effect is also exerted on markers of endothelial function. In this study, tadalafil (20 mg) on alternate days or on demand was administered for 4 weeks. The markers of endothelial function evaluated were vascular cell adhesion molecule-1, intercellular cell adhesion molecule, ET-1, insulin and C-reactive protein. The results showed that chronic, but not on demand tadalafil improves endothelial function with sustained effects after its discontinuation. Chronic treatment also produced a dramatic increase in morning erections, which determines better oxygenation to the penis, thus providing a rationale for vascular rehabilitation.
Finally, in another study, conducted in diabetic patients, after once-daily treatment with tadalafil 2.5 mg or 5 mg for 12 weeks, endothelial dysfunction biomarkers (C-reactive protein, nitrotyrosine, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1) did not change significantly. The authors concluded that the inability to show an effect of tadalafil on biomarkers of endothelial dysfunction in their present study may relate to several factors: methods of detection less sensitive compared with brachial artery dilation, too short observation period, too low doses of tadalafil, within normal range biomarker baseline values (except nitrotyrosine) or severe underlying vascular pathology in this particular study group. 20 In conclusion, this study showed that chronic tadalafil administration (5 mg daily for 90 days) reduces endothelial apoptosis and that this effect disappears within 6 months from tadalafil discontinuation; this aspect was evaluated by the changes of serum concentrations of EMP that probably anticipate the worsening of the instrumental (Doppler) and clinical (questionnaire scores) parameters. Studies of longer duration and different schemes of treatment should be conducted to search for a more durable effect on the endothelium and/or possible changes of other above-mentioned parameters.
